Narrow Results

APAC drug delivery devices market to reach $5.4 billion in 2023.

Mergermarket released Global Pharma, Medical & Biotech trend report for Q3 2017.

Global BioLife develops breakthrough modified sugar.

Breakthrough noodle formula with low-glycemic score of 38.

Aphria ships first medical cannabis oil to Australia’s Medlab for clinical trial.

Envirotainer doubles e-technology capacity across Asia.

Genesis CancerCare Queensland is first in Asia-Pacific to use Elekta’s Venezia Brachytherapy Applicator.

iX Biopharma secures European patent for WaferiX drug delivery technology.

Shingrix approved in the US for prevention of shingles in adults aged 50 and over.

First three-monthly long-acting treatment for schizophrenia patients in Singapore.

China, Brazil and Russia named by healthcare companies as riskiest markets for compliance and regulation.

New survey shows patients in Asia Pacific fail to recognize their fragility fracture is due to osteoporosis.

Healthcare community join forces to fight growing epidemic of fragility fractures caused by osteoporosis.

Drugs to watch 2018

First Pharmaceutical Regulation Graduate Certificate programme offered by Duke-NUS CoRE

Evonik intensifies research into regenerative medicine

SGInnovate completes investment in deep tech startup NDR Medical Technology

Australian biotech AdAlta makes improvements to lung fibrosis drug

AI and blockchain will counteract unsustainability of soaring drug prices

Availability of orphan medicines varies between European countries